Electra Therapeutics, Inc.
ETRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002088082
In the last 90 days, Electra Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $20.0M in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ETRA, Q2 2026
No superinvestor reported holding ETRA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Electra Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)5:35 PM ET | Sep 21 | 2 days | Gordon Carl LDirector, 10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +313.8%1.76M after | 2 lotsDuplicate filing |
| Sep 23, 2026 (view filing)5:29 PM ET | Sep 21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +313.8%1.76M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Electra Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding ETRA in 13F filings for Q2 2026.